Clinical Trial Update: BiOSS LIM C vs 2nd Generation DES in Non-LM Bifurcations [Phase 4]

View source ↗

Summary

Phase 4 clinical trial update comparing BiOSS LIM C bifurcation stent with a second-generation drug-eluting stent in non-left-main coronary bifurcation lesions;…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Coronary Artery Disease

Drugs mentioned

• BiOSS LIM C
• Second-generation drug-eluting stent (drug-eluting stent)

Snippet

Sponsor: Central Clinical Hospital of the Ministry of Internal Affairs and Administration, Warsaw, Poland | Conditions: Coronary Artery Disease | Phase 4 | Status: UNKNOWN